As the Northern hemisphere is about to enter winter, the threat of COVID-19 looms even greater than before. Cold air and more time spent indoors are likely to increase the…
Category: Patents
Patenting to Fight Pandemics: The Canadian Story
This blog was originally published here. COVID-19 first appeared in December 2019. By March 2020, the virus was spreading around the world with increasing speed, leading the World Health Organization to declare…
Pharmaceutical Counterfeiting: What is it and Current Issues with IP Regulations
What is Pharmaceutical Counterfeiting? Counterfeit goods are an age-old consequence of economic markets. These consequences are especially troubling when raising concerns about the delivery of prescription medicines that the public…
Impact of COVID-19 on Intellectual Property system in Canada
Flexibility Demonstrated by IP Offices due to COVID19: As current and prospective intellectual property (IP) owners around the world continue to find themselves in a difficult situation as a result…
US Pharma Company, Gilead Sciences, Expands Access to COVID-19 Treatment- Experts Remain Skeptical of Long-Term Demands
As healthcare systems around the world continue to struggle with managing the rates of transmission and mortality in patients with COVID-19, an announcement made in late April by Dr. Anthony…
What USMCA Ratification Means for IP in Canada
On March 13, 2020, Canada’s House of Commons and Senate both passed Bill C-4, the Canada-United States-Mexico Agreement Implementation Act (the “Act”), which received royal assent the same day. This…